Cargando…
Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome
Diabetes-associated chronic kidney disease is a pandemic issue. Despite the global increase in the number of individuals with this chronic condition together with increasing morbidity and mortality, there are currently only limited therapeutic options to slow disease progression. One of the reasons...
Autores principales: | Lecamwasam, Ashani, Ekinci, Elif I., Saffery, Richard, Dwyer, Karen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555227/ https://www.ncbi.nlm.nih.gov/pubmed/32927866 http://dx.doi.org/10.3390/biomedicines8090341 |
Ejemplares similares
-
Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease
por: Lecamwasam, Ashani, et al.
Publicado: (2020) -
Identification of Potential Biomarkers of Chronic Kidney Disease in Individuals with Diabetes: Protocol for a Cross-sectional Observational Study
por: Lecamwasam, Ashani R, et al.
Publicado: (2020) -
Blood Plasma Metabolites in Diabetes-Associated Chronic Kidney Disease: A Focus on Lipid Profiles and Cardiovascular Risk
por: Lecamwasam, Ashani, et al.
Publicado: (2022) -
DNA methylation profiling of genomic DNA isolated from urine in diabetic chronic kidney disease: A pilot study
por: Lecamwasam, Ashani, et al.
Publicado: (2018) -
Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease
por: Khanijou, Vuthi, et al.
Publicado: (2022)